Sanofi
3 documented AI deployments at Sanofi, across 1 industry. Each one links to the public source it was taken from.
Paris, France · Founded 2004 · sanofi.com · WikipediaSource: Wikidata, 2026-11-01
Public AI record
Sanofi has 3 documented public AI cases on the hub, too few for a score. AI development platform and life sciences innovation are common among peers but not yet documented at Sanofi.
A record score appears once Sanofi has 5 documented public cases. The peer comparison below already uses what is on record.
First documented case Oct 2023, latest Jun 2026. Cloud providers named: AWS, Microsoft.
Compared with peers
Against 6 other pharma companies on the hub.
What peers document
- Drug discovery6 of 6 peers · here too100%
- AI development platform2 of 6 peers33%
- Life sciences innovation2 of 6 peers33%
- Patient engagement2 of 6 peers33%
Gaps against the industry
- AI development platform: 33% of peers, not documented at Sanofi yet
- Life sciences innovation: 33% of peers, not documented at Sanofi yet
- Patient engagement: 33% of peers, not documented at Sanofi yet
Signature use cases
No peer on the hub documents ai agents or therapeutics research.
Stack and approach vs peers
- Peer cases name Microsoft 59%, AWS 48%.
- AI agents: 33% of Sanofi's cases vs 17% for peers.
- Cases from the last 12 months: 67% vs 27% for peers.
Deployments
3 deployments at Sanofi, newest first.
- 16 Jun 2026PharmaFrance
Sanofi builds Concierge, an agentic generative AI assistant on Amazon Bedrock
Sanofi · AI agents · AWS
Sanofi built Concierge in-house on AWS as a unified, agentic AI companion for its global workforce, using Amazon Bedrock for model flexibility and planning to add Amazon Bedrock AgentCore for orchestration. The system gives employees a single conversational interface for finding information, generating content, completing tasks, and discovering specialized agents across the company.
AgenticProduction
- 29 Apr 2026PharmaFrance
Sanofi Digital Accelerator uses AWS SageMaker for predictive AI and deploys Bedrock for generative AI pilots
Sanofi · Drug discovery · AWS
Sanofi launched its Digital Accelerator to speed up digital innovation across research and development, clinical, commercial, and manufacturing workflows. The initiative aims to shorten the time from discovery to therapy and improve patient, provider, and employee experiences through AI-powered solutions.
Production
24 htime - 25 Oct 2023PharmaFrance
Sanofi personalizes cancer treatment and accelerates drug discovery using advanced AI
Sanofi · Therapeutics research · Microsoft
Sanofi, a global pharmaceutical leader based in France, is leveraging advanced AI and Microsoft Azure technologies to transform two core areas: cancer treatment optimization and drug discovery acceleration. In partnership with AI-driven firms like Owkin, BioMap, and Exscientia, Sanofi employs large-scale federated learning, multimodal medical data analysis, and protein large language models (LLMs) to: 1) discover prognostic biomarkers and novel therapeutic targets in aggressive cancer subtypes; and 2) automate protein engineering and minor molecule candidate discovery for new drugs. Their Responsible AI framework guides transparent, ethical implementation. While most AI-enabled pipelines are recently launched or ongoing, the company has announced faster drug identification timelines, expansion into immunology, and progress of novel therapeutic agents to preclinical phases—all enabled by secure, scalable Azure cloud services. The implementation involves collaborations and integration between proprietary data, cloud AI services, and advanced analytics for precision medicine.
What it builds
AI agents is the most common pattern in these deployments: 1.
Cloud providers named
AWS is named in 2 of these deployments.
- AWS67% of these2
- Microsoft33% of these1